Pharmacy -- Enterobiasis (Threadworms/Pinworms)

PATIENT DETAILS:
Name: Mr. Carter
Phone number: 
Personal Health Number (PHN): 

GENERAL:
PharmaNet has been checked. Eligibility documented.

Objective:
REASON FOR VISIT:
Follow-up of chronic lower back pain and depression.

ASSESSMENT:
Mr. Carter reports persistent lower back pain that is present throughout the day, with increased severity in the mornings and after prolonged sitting. He experiences significant sleep disturbance due to the pain. He describes a markedly depressed mood, with loss of interest in previously enjoyed activities and social withdrawal, rarely leaving his home. He acknowledges passive thoughts of death but denies active suicidal ideation. He feels that his chronic pain and depression are mutually reinforcing, leading to a sense of being trapped in a cycle. No mention of exposure to contaminated food or other risk factors. No household member details provided.

RED FLAGS/REFERRAL INDICATIONS:
No active suicidal ideation.

Subjective:
PAST MEDICAL HISTORY:
Chronic lower back pain and depression. No prior use of SNRIs or similar medications.

CURRENT MEDICATIONS:
No current medications documented. PharmaNet checked for confirmation.

ALLERGIES:
No allergy information provided.

Assessment:
DIAGNOSIS:
Enterobiasis (B80)

Plan:
RECOMMENDATIONS:
- No patient education regarding enterobiasis provided.
- Mr. Carter is advised to avoid scratching the area, keep his fingernails short, wash his hands regularly (especially before and after using washroom and eating/preparing food), frequent showers (baths should be avoided). He should avoid using shared showers or bath towels. Bedding should be washed frequently and dried on high heat. The toilet seat should be cleaned daily.
- Treatment: No treatment for enterobiasis prescribed or documented.
- Treatment of all members of the household concurrently is recommended, even if asymptomatic.
- Mr. Carter has been advised of the importance of repeating the treatment 2 weeks after the initial dose. This is vital to ensure eradication as pharmacotherapy is not effective on eggs.

MONITORING/FOLLOW UP:
- Follow up in 1-2 weeks to assess efficacy and adherence to treatment.
- Mr. Carter is advised to contact his primary care provider if there is worsening of symptoms or no improvement 1 week following the second dose.

Date:
2026-02-09

PHARMACY INFORMATION:
Pharmacy name: 
Pharmacy phone number: 
Pharmacy address: 
Pharmacist name: 
Pharmacist license number: